Trial intelligence / Profile preview

Alpha-Lipoic Acid in PCOS

NCT02666170Unknown

Sponsor
Università Cattolica del Sacro Cuore
Start
Jan 2016
Primary completion
Sep 2016
Modality
Small Molecules
01

Overview

Open-label, single-arm trial of alpha-lipoic acid in polycystic ovary syndrome (PCOS), sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Number of cycles in six months of therapy at 6 months. Status: unknown.

02

Drugs

alpha-lipoic acid
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT02666170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02666170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call